Clinical trial
Safety Study of IL-7 in HIV-infected Patients (Inspire)
NCT00477321 · Cytheris SA, Industry · Completed
Key facts
| NCT number | NCT00477321 |
|---|---|
| Title | Safety Study of IL-7 in HIV-infected Patients (Inspire) |
| Official title | A Ph I/IIa Rand Placebo Ctrl, S-Blind Multictr Dose-Esc Study of SC Intermittent Interleukin-7 CYT107 in Chronically HIV-Infected Pts With CD4 T Lymphocyte Counts 101-400 Cells-/mm(3) and Plasma HIV RNA Less Than 50 Copies/mL After at Least 12 M of HAART |
| Lead sponsor | Cytheris SA, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | HIV Infections, Lymphopenia |
| Intervention type | Drug |
| Interventions | CYT 107 |
| Enrollment | 30 |
| Start date | May 1, 2007 |
| Primary completion | Oct 1, 2009 |
| Completion | Jul 1, 2010 |
| First posted | May 23, 2007 |
| Last update posted | Oct 18, 2012 |
| Countries | Canada, France, Italy, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: